Nekkab, N. and Penny, M. A.. (2022) Accelerated development of malaria monoclonal antibodies. Cell Rep Med, 3 (10). p. 100786.
![[img]](https://edoc.unibas.ch/style/images/fileicons/application_pdf.png) |
PDF
- Published Version
Available under License CC BY (Attribution). 195Kb |
Official URL: https://edoc.unibas.ch/91568/
Downloads: Statistics Overview
Abstract
L9LS, a potent and safe antimalarial monoclonal antibody, demonstrated 88% protective efficacy against infection in a phase 1 trial in healthy adults.(1) These promising results are the first of many to usher in a potential new era of malaria prevention.
| Faculties and Departments: | 09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) 09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Epidemiology and Public Health (EPH) > Disease Modelling > Disease Modelling and Intervention Dynamics (Penny) |
|---|---|
| UniBasel Contributors: | Nekkab, Narimane and Penny, Melissa |
| Item Type: | Article, refereed |
| Article Subtype: | Further Journal Contribution |
| ISSN: | 2666-3791 (Electronic)2666-3791 (Linking) |
| Note: | Publication type according to Uni Basel Research Database: Journal item |
| Language: | English |
| Related URLs: | |
| Identification Number: |
|
| edoc DOI: | |
| Last Modified: | 29 Dec 2022 15:46 |
| Deposited On: | 29 Dec 2022 15:46 |
Repository Staff Only: item control page